Sharon Kedar, CFA
Cofounder, Partner, Northpond Ventures
Sharon Kedar. Ms. Kedar has served as a member of our board of directors since July 2020. Ms. Kedar is a Co-Founder and Partner of Northpond Ventures, a science, medical and technology focused venture capital firm founded in 2018. Prior to founding Northpond, Ms. Kedar spent fifteen years at Sands Capital Management, an investor in leading innovative businesses, where she served as Chief Financial Officer and was active in all key functions of the company. In addition to Codex DNA, Ms. Kedar is a board director of other emerging companies, including 908 Devices, Inc., Emulate, Inc., Encodia, Inc. and IsoPlexis Corporation. Ms. Kedar has also served on the boards of Ultivue, Inc. and Vizgen, Inc. Ms. Kedar is a Chartered Financial Analyst (CFA) charterholder and has B.A. in Economics from Rice University and an M.B.A. from Harvard Business School.